The Relative Strength (RS) Rating for Cushman & Wakefield entered a new percentile Tuesday, as it got a lift from 69 to 74.
IBD's unique RS Rating tracks market leadership by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
Decades of market research reveals that the top-performing stocks tend to have an RS Rating north of 80 in the early stages of their moves. See if Cushman & Wakefield can continue to rebound and clear that threshold.
How To Invest In Stocks In Both Bull And Bear Markets
Cushman & Wakefield is not currently near a potential buying area. See if the stock goes on to form a sound pattern that could launch a new move.
Earnings grew 10% last quarter, up from -9% in the prior report. Revenue also increased, from -5% to 3%.
The company earns the No. 25 rank among its peers in the Real Estate-Development/Operations industry group. Howard Hughes Holdings, Amrep Corp and CBRE Group are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
